InMed Pharmaceuticals insider buying draws attention after 10% owner Vivo Opportunity purchases $391,600 in shares.
Insider Trading
Table of Contents
June 11, 2026
InMed Pharmaceuticals Inc. (NASDAQ: INM) disclosed that Vivo Opportunity, LLC, a 10% owner, purchased approximately $391,600 worth of company shares across multiple transactions, according to a Form 4 filing with the U.S. Securities and Exchange Commission (SEC).
The purchases occurred between May 20 and June 8, 2026, at average prices ranging from $1.52 to $1.69 per share.
After the latest reported transaction, Vivo Opportunity reported indirect ownership of 72,535 shares through Vivo Opportunity Cayman Fund, L.P. The filing also listed related indirect holdings through Vivo Opportunity Fund Holdings, L.P.
InMed Pharmaceuticals is a pharmaceutical company focused on developing drug candidates and cannabinoid-based therapies for diseases with unmet medical needs.
The filing is notable because Vivo Opportunity purchased INM shares across nine transaction dates rather than making a single isolated buy.
The activity included purchases on May 20, May 21, May 29, June 1, June 2, June 3, June 4, June 5, and June 8.
That pattern shows steady accumulation over several weeks.
The total purchase value was approximately $391,600, which is below the $500,000 to $1 million insider-buying range often viewed as a stronger signal.
That does not make the filing irrelevant, but it lowers the signal strength compared with larger CEO, CFO, or clustered insider purchases.
The stronger part of this filing is not the dollar amount. It is the repeated buying from a 10% owner across multiple dates.
The purchases were reported as indirectly owned through Vivo Opportunity Fund Holdings, L.P. and Vivo Opportunity Cayman Fund, L.P.
That matters because the buying appears tied to an investment vehicle rather than a direct executive purchase. Fund-level insider buying can still be relevant, but it may reflect portfolio positioning or ownership strategy rather than a direct operating signal from management.
Insider buying becomes more meaningful when it involves larger dollar amounts, repeated purchases, senior executives, or multiple insiders buying within a short period.
Platforms like LevelFields track insider transactions alongside other market-moving events, helping investors identify when insider buying exceeds key thresholds and may signal a meaningful shift in sentiment.
Join LevelFields now to be the first to know about events that affect stock prices and uncover unique investment opportunities. Choose from events, view price reactions, and set event alerts with our AI-powered platform. Don't miss out on daily opportunities from 6,300 companies monitored 24/7. Act on facts, not opinions, and let LevelFields help you become a better investor.

AI scans for events proven to impact stock prices, so you don't have to.
LEARN MORE